Navigation Links
Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
Date:9/23/2011

4.0 weeks (range 9-112 weeks) in the placebo arm(1).

In the study, the definition of angiomyolipoma response included a reduction of at least 50% relative to baseline in the sum of the volumes of all target lesions, and the absence of new lesions greater than or equal to one centimeter in diameter, with a confirmed response by radiographic scan approximately 12 weeks later(1).

Everolimus demonstrated superiority to placebo for both secondary endpoints assessed: skin lesion response rate and time to angiomyolipoma progression per central review. Skin lesion response rate, defined as the proportion of patients with a best overall skin lesion response of either complete clinical response or partial response, was 26% in patients (20 of 77) on everolimus and 0% (0 of 37) on placebo (p=0.0002). Median time to angiomyolipoma progression (time from date of randomization to date of first documented angiomyolipoma progression) was 11.37 months in the placebo arm and was not reached in the everolimus arm. Progressions were observed in 4% of patients (3 of 79) on everolimus and 21% (8 of 39) on placebo. The estimated progression-free rates at six months were 98% on everolimus and 83% on placebo (p<0.0001)(1).

The most common adverse events (AEs) in the everolimus arm (with an incidence of at least 20%) included stomatitis, nasopharyngitis, acne, headache, cough and hypercholesterolaemia. Renal events were less frequent in the everolimus arm compared to the placebo arm. The most common Grade 3 AEs in the everolimus arm (with an incidence of at least 2%) were amenorrhea, aphthous stomatitis, decreased blood phosphorus and mouth ulceration. Single Grade 4 cases of convulsion, increased blood uric acid, hypertensive crisis and neutropenia were reported in the everolimus arm(1).

Adverse events observed in this study were consistent with the known safety profile of everolimus in the TSC setting. Adverse events leading to trial discontinuation were rep
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
3. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
4. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
5. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
6. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
7. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
8. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
9. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
10. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
11. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 ... the U.S. commercial launch of its foot plating system ... Paragon 28.  The GORILLA TM R3CON PLATING SYSTEM ... the Monster TM & Mini-Monster TM Screw ... Comprised of 10 interchangeable subsystems, the GORILLA TM ...
(Date:9/22/2014)... Sept. 22, 2014 The western European ... It is largely a replacement market with fewer ... mergers, acquisitions and partnerships are redefining competitive landscape ... research service provides details about revenue forecasts, unit ... trends across the country. The changing landscape makes ...
(Date:9/22/2014)... 2014 ... the addition of the  "Global Freeze Drying ... Market - Forecast to 2019"  report to ... ,The global freeze drying market was valued ... expected to reach at $2,655.9 million by ...
Breaking Medicine Technology:Paragon 28, Inc. Launches the GORILLA(TM) R3CON PLATING SYSTEM 2Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3
... 4, 2011 Reportlinker.com announces that a new market ... Personalized Medicine - scientific & commercial aspects ... aim of personalized medicine or individualized treatment is to ... in some cases, even to design the appropriate treatment ...
... a proposed Settlement in a class action lawsuit involving ... treat a variety of medical conditions including: cancer, HIV, ... blood issues, and many other conditions.  These drugs are ... This lawsuit is not about whether these drugs ...
Cached Medicine Technology:Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 2Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 3Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 4Medicare Part B Subscribers Who Made a Percentage Co-Payment for Certain Drugs May Be Able To Get a Refund from a Class Action Settlement 2
(Date:9/22/2014)... McMaster scientists have found that an anticonvulsant drug may ... , Although dozens of antibiotics target what bacteria do, ... of bacteria are created, and they found there is ... is important as there is growing concern worldwide about ... ineffective. The World Health Organization has declared that antibiotic ...
(Date:9/22/2014)... US (PRWEB) September 22, 2014 This ... perspectives on stakeholder management needs for the Prostate Cancer ... Heartbeat Experts on stakeholder strategies for any launching Prostate ... points of differentiation within an increasingly crowded market , ... The impact of identifying community-based thought leaders and ...
(Date:9/22/2014)... Kessler researchers have published a pilot study showing ... in people with multiple sclerosis (MS). Improvements ... stress, and pain. "Development and effectiveness of ... MS: Description and outcomes" was epublished ahead of ... Journal of MS Care (doi: 10.7224/1537-2073.2013-045). The ...
(Date:9/22/2014)... New York, New York (PRWEB) September 22, 2014 ... risks associated with the use of power morcellators ... Liebhard LLP notes a new report detailing the ... despite warnings from federal regulators that specifically discouraged ... these physicians believe that the potential cancer risks ...
(Date:9/22/2014)... Barbara Bronson Gray HealthDay Reporter ... every pregnant woman wonders: What can I do to help ... iron supplements as prescribed may play a role in reducing ... (ASD). The researchers found that mothers of children with ... before and during pregnancy than those whose children seem to ...
Breaking Medicine News(10 mins):Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3
... announced today that ALIGN(R) is now available through ... builds and maintains a natural defense against ... as constipation, diarrhea, abdominal discomfort, urgency, gas and ... contains Bifantis(R) (Bifidobacterium infantis 35624), a natural probiotic ...
... the demand for healthcare services set to more ... years, the Indian healthcare industry appears ripe for ... healthcare budgets have attracted big ticket foreign ... clinical trials, medical devices and equipment, healthcare services, ...
... that will be presented at the annual meeting of ... (July 7-11, 2007), scientists implemented a successful bioeradication ... Victoria. , Two insect biocontrol species, weevils ... removal, to control the highly invasive water hyacinth, which ...
... demonstrated conclusively that a specific protein and its signaling ... essential to the creation and repair of the brains ... mouse models points the way to developing treatments or ... repair in children and adults. The paper will be ...
... in the Pennsylvania government after a deal was struck between ... 24,000 state workers returned to work after they were sent ... all sides can say that they achieved some of their ... declaring himself "very satisfied with where we came out." ...
... to consider a radical change in their lifestyles, if ... a report prepared by the Centre for Alternative Technology ... report, the lifestyle changes could include having vegetarian meals, ... ,Paul Allen, CAT's Development Director, was quoted ...
Cached Medicine News:Health News:Government Policies and Booming Economy Keep Indian Healthcare in Top Shape 2Health News:Government Policies and Booming Economy Keep Indian Healthcare in Top Shape 3Health News:Water Hyacinth is Used for Health Improvements in Africa 2Health News:Water Hyacinth is Used for Health Improvements in Africa 3Health News:Water Hyacinth is Used for Health Improvements in Africa 4Health News:Specific Protein is Instrumental in Myelination 2Health News:Specific Protein is Instrumental in Myelination 3Health News:Pennsylvania Government's Partial Shutdown Ends 2Health News:Radical Change in the Lifestyle Might Bring a Greener Future for Brits 2
... is a complete practice and business ... optometrists, opticians and ophthalmologists- It is ... seeking a graphically rich and intuitive ... of solid features and functionality- The ...
... 70 hematology system delivers a ... Designed for speed and accuracy, ... cost-effectiveness with impressive productivity. The ... on its own or twinned ...
The SE-9500 automated hematology analyzerprovides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
Medicine Products: